264 results Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products. Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency. Stibbe advises on the IPO of Tornier Stibbe advises Cellerix Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix. Podcast: Data en financiële instellingen In deze podcast praten Roderik Vrolijk en Frederiek Fernhout van Stibbe in Amsterdam en Joran Iedema van Stibbe StartsUP-deelnemer Dyme over Fintech, PSD2 en het gebruik van data door financiële instellingen. Stibbe in panel Generative Artificial Intelligence event Op donderdag 27 juni nam Stibbe deel aan een event over Generative Artificial Intelligence en de mogelijke betekenis en impact ervan op verschillende spelers en belanghebbenden in de juridische sector. The latest Legal Updates straight to your mailbox We publish high-quality legal knowledge and insights on our website on a daily basis. If you would like to be promptly informed about the latest developments within your areas of interest, we invite you to sign up for our Legal Updates. De laatste Legal Updates direct in uw mailbox Dagelijks publiceren wij op onze website hoogwaardige juridische kennis en vooruitzichten. Wilt u snel op de hoogte zijn van de meest actuele ontwikkelingen binnen uw interessegebieden? Meld u dan aan voor onze Legal Updates. Les dernières actualités juridiques directement dans votre boîte e-mail Vous souhaitez recevoir rapidement les informations concernant les derniers développements dans les domaines qui vous intéressent? Nous vous invitons à vous inscrire à nos Legal Updates. DNB's AI Guidance: balancing innovation with prudence The Dutch Central Bank (De Nederlandsche Bank, DNB) has shared new key considerations on the use of artificial intelligence in the insurance sector. Stibbe advised MultiSafePay Stibbe advised MultiSafePay on all corporate and financial regulatory aspects of the acquisition of MultisafePay by ANT. The Guidelines for providers of General Purpose AI Models are here: the 10^23 FLOPS question? The European Commission published Guidelines for GPAI model providers, helping them understand AI Act requirements for general purpose AI models before the 2 August 2025 compliance deadline. Navigating the Dutch advertising landscape: key legal insights from the SRC's 2024 annual report The Stichting Reclame Code (SRC) has issued its annual report, providing crucial insights for legal practitioners and companies in the advertising, marketing, and e-commerce sectors. This comprehensive analysis reveals significant trends. Stibbe advises the SCHMID Group Stibbe, together with Gleiss Lutz, has advised the SCHMID Group on its business combination with Pegasus Digital Mobility Acquisition Corp. and listing on NASDAQ. Compensation after infringement of the General Data Protection Regulation: European developments The General Data Protection Regulation (GDPR) is one of the most significant development in the European data strategy in the past years and is continuously evolving. Een inbreuk op de AVG geeft niet zonder meer recht op schadevergoeding: Europese ontwikkelingen De Algemene Verordening Gegevensbescherming (de “AVG”) is één van de meest ingrijpende ontwikkelingen binnen de Europese datastrategie van de afgelopen jaren en nog steeds volop in ontwikkeling. Legal Considerations for Artificial Intelligence in the Life Sciences Sector This blogpost explores the evolving legal landscape governing AI in life sciences, with a focus on medical device regulation, data protection and intellectual property. Alexander Collot d'Escury Senior Associate Amsterdam Pagination Previous page Page 12 Page 13 Current page 14 Page 15 Next page
Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products.
Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency.
Stibbe advises Cellerix Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix.
Podcast: Data en financiële instellingen In deze podcast praten Roderik Vrolijk en Frederiek Fernhout van Stibbe in Amsterdam en Joran Iedema van Stibbe StartsUP-deelnemer Dyme over Fintech, PSD2 en het gebruik van data door financiële instellingen.
Stibbe in panel Generative Artificial Intelligence event Op donderdag 27 juni nam Stibbe deel aan een event over Generative Artificial Intelligence en de mogelijke betekenis en impact ervan op verschillende spelers en belanghebbenden in de juridische sector.
The latest Legal Updates straight to your mailbox We publish high-quality legal knowledge and insights on our website on a daily basis. If you would like to be promptly informed about the latest developments within your areas of interest, we invite you to sign up for our Legal Updates.
De laatste Legal Updates direct in uw mailbox Dagelijks publiceren wij op onze website hoogwaardige juridische kennis en vooruitzichten. Wilt u snel op de hoogte zijn van de meest actuele ontwikkelingen binnen uw interessegebieden? Meld u dan aan voor onze Legal Updates.
Les dernières actualités juridiques directement dans votre boîte e-mail Vous souhaitez recevoir rapidement les informations concernant les derniers développements dans les domaines qui vous intéressent? Nous vous invitons à vous inscrire à nos Legal Updates.
DNB's AI Guidance: balancing innovation with prudence The Dutch Central Bank (De Nederlandsche Bank, DNB) has shared new key considerations on the use of artificial intelligence in the insurance sector.
Stibbe advised MultiSafePay Stibbe advised MultiSafePay on all corporate and financial regulatory aspects of the acquisition of MultisafePay by ANT.
The Guidelines for providers of General Purpose AI Models are here: the 10^23 FLOPS question? The European Commission published Guidelines for GPAI model providers, helping them understand AI Act requirements for general purpose AI models before the 2 August 2025 compliance deadline.
Navigating the Dutch advertising landscape: key legal insights from the SRC's 2024 annual report The Stichting Reclame Code (SRC) has issued its annual report, providing crucial insights for legal practitioners and companies in the advertising, marketing, and e-commerce sectors. This comprehensive analysis reveals significant trends.
Stibbe advises the SCHMID Group Stibbe, together with Gleiss Lutz, has advised the SCHMID Group on its business combination with Pegasus Digital Mobility Acquisition Corp. and listing on NASDAQ.
Compensation after infringement of the General Data Protection Regulation: European developments The General Data Protection Regulation (GDPR) is one of the most significant development in the European data strategy in the past years and is continuously evolving.
Een inbreuk op de AVG geeft niet zonder meer recht op schadevergoeding: Europese ontwikkelingen De Algemene Verordening Gegevensbescherming (de “AVG”) is één van de meest ingrijpende ontwikkelingen binnen de Europese datastrategie van de afgelopen jaren en nog steeds volop in ontwikkeling.
Legal Considerations for Artificial Intelligence in the Life Sciences Sector This blogpost explores the evolving legal landscape governing AI in life sciences, with a focus on medical device regulation, data protection and intellectual property.